RNU6-320P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU6-320P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-320P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU6-320P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-320P expression acts as an unfavorable survival marker.

UCEC, OV, and KIRC are the cancer types where RNU6-320P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECOSTertileAll0.0950.680<.00190view →
OVDFSTertileAll0.2540.542.00654view →
KIRCOSTertileAll0.2520.662<.00124view →
STADDFSTertileAll0.4220.721.01218view →
CESCDFSTertileAll0.1490.740.00118view →
Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-320P–UCEC (OS)

Kaplan–Meier survival curve for RNU6-320P RNA-high vs -low samples in UCEC.

Open the UCEC breakdown →

Exploration